Ken Griffin Tff Pharmaceuticals, Inc. Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.43 - $0.77 $10,234 - $18,326
-23,800 Reduced 51.52%
22,400 $10,000
Q1 2023

May 15, 2023
SELL
$0.62 - $1.1 $7,874 - $13,970
-12,700 Reduced 21.56%
46,200 $31,000
Q4 2022

Feb 14, 2023
BUY
$0.84 - $100.75 $22,932 - $2.75 Million
27,300 Added 86.39%
58,900 $61,000
Q3 2022

Nov 14, 2022
SELL
$4.61 - $116.0 $94,044 - $2.37 Million
-20,400 Reduced 39.23%
31,600 $128,000

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0
View Full List

About TFF Pharmaceuticals, Inc.

TFFP Quotes by TradingView
  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $1.53M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email